Stay updated on Pembrolizumab Maintenance in sNSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Maintenance in sNSCLC Clinical Trial page.

Latest updates to the Pembrolizumab Maintenance in sNSCLC Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page’s revision indicator was updated from **v3.5.2** to **v3.5.3**. This reflects an underlying site/version change rather than a change to the trial’s content.SummaryDifference0.1%

- Check22 days agoChange DetectedAdded Revision: v3.5.2; Removed Revision: v3.5.0.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page revision label was updated from v3.4.3 to v3.5.0. This change does not affect study details or core page behavior.SummaryDifference0.1%

- Check58 days agoChange DetectedThe page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.1%

- Check65 days agoChange DetectedNo additions or deletions were detected; the page content appears unchanged.SummaryDifference0.1%

- Check86 days agoChange DetectedRevision: v3.4.2 was added; prior updates and notices, including Revision: v3.4.1 and a government funding/operating status notice, were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Pembrolizumab Maintenance in sNSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Maintenance in sNSCLC Clinical Trial page.